June 24, 2024

The Global Antibodies Market Is Driven By Rising Need For Sophisticated Research And Development

The global Antibodies market has experienced significant growth over the past decade due to the expanding applications of antibodies in various diagnostic and therapeutic areas. Antibodies are widely used as diagnostic agents in various immunoassays and biochemical techniques such as enzyme-linked immunosorbent assay (ELISA), immunoblotting, immunohistochemistry and flow cytometry. They are also used as therapeutic agents and are at the forefront of drug innovation. The increasing demand for protein-based drugs, expanding applications of monoclonal antibodies in oncology, and active government support for biologics drug development are some of the key factors driving the growth of global antibodies market.

The global Antibodies Market is estimated to be valued at US$ 224083.5 Mn in 2023 and is expected to exhibit a CAGR of 16.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
One of the major trends driving growth in the antibodies market is the rising demand for personalized therapy. Personalized therapy involves tailoring treatment to the individual characteristics of each patient. With advances in genomic technologies, targeted therapies are being developed for specific mutations seen in subgroups of patients. This has led to development of various companion diagnostics and sophisticated biomarkers for selection of appropriate candidates for targeted therapies. Rising demand for personalized healthcare is leading pharmaceutical companies to develop novel antibody drug conjugates (ADCs) and bispecific antibodies with improved selectivity and efficacy. This trend is poised to significantly benefit antibodies market over the forecast period.

Porter’s Analysis
Threat of new entrants: The Antibodies market requires large capital investments and strict regulatory environment which poses high entry barriers for new players.
Bargaining power of buyers: Individual buyers have low bargaining power compared to large pharmaceutical and biotechnology companies which are major buyers in this market.
Bargaining power of suppliers: A few large players dominate the supply market which gives them a strong position in negotiating prices with buyers.
Threat of new substitutes: There is no substitute for antibodies currently and development of new alternatives requires huge investments of time and money.
Competitive rivalry: The antibodies market is highly fragmented with the presence of various global and regional vendors. Competition is based on product quality, innovation, and pricing.

Key Takeaways

The Global Antibodies Market Size is expected to witness high growth over the forecast period.

Regionally, North America is expected to dominate the market throughout the analysis period. High development and production of therapeutic antibodies along with presence of majority of key players drive the regional market. Asia Pacific is anticipated to be the fastest growing market owing to growing biotechnology research, increasing healthcare spending, and rising prevalence of chronic diseases.

Key players operating in the antibodies market are Bose Corporation, Beats Electronics, 3M, Alclair Audio, Audio-Technica Ltd, Panasonic Corporation, Apple Inc., Bowers & Wilkins Group Ltd., David Clark Inc., GN Group, Harman International, Inc., Sony Corporation, Logitech International S.A., Koninklijke Philips N.V., Pioneer Corporation, and Sennheiser Electronic GmbH & Co. KG. Competition between these players is based on product quality, durability, and pricing. Major players are focusing on new product launches and collaboration activities to strengthen their market position.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it